Predictors of failure to rescue after fenestrated-branched endovascular aortic repair of thoracoabdominal aortic aneurysms
- PMID: 40054790
- DOI: 10.1016/j.jvs.2025.02.032
Predictors of failure to rescue after fenestrated-branched endovascular aortic repair of thoracoabdominal aortic aneurysms
Abstract
Objective: Failure to rescue (FTR), defined as mortality due to failure in responding to in-hospital complications, is an important quality indicator. This study aimed to assess incidence and predictors for FTR among centers performing fenestrated-branched endovascular aortic repair (FB-EVAR) of thoracoabdominal aortic aneurysms (TAAA).
Methods: Consecutive patients treated by FB-EVAR for TAAAs between 2005 and 2022 in 27 centers of the International Multicenter Aortic Research Group were analyzed. Data were obtained from the United States Aortic Research Consortium, which contains prospectively collected data of physician-sponsored investigational device exemption studies from 10 centers, and retrospective center data from Europe and New Zealand. FTR was defined as in-hospital mortality following ≥1 major adverse event (MAE). Primary endpoints were rates of postoperative MAEs, including major cardiac (myocardial infarction, cardiovascular collapse, acute congestive heart failure) and respiratory events, major stroke, paraplegia, acute kidney injury (AKI), and bowel ischemia requiring surgical resection or escalation of care and FTR. Multivariate analysis was performed to identify predictors for MAEs and FTR.
Results: There were 3634 patients (68% males; mean age, 71 ± 9 years) treated by FB-EVAR for TAAAs. Technical success was achieved in 94%, with 5% in-hospital mortality. Median incidences of MAEs and FTR were 27% (interquartile range, 18%-33%) and 15% (interquartile range, 6%-21%). There was a significantly (33% vs 20%; P < .001) higher rate of MAEs among centers with annual volume below the median (11 cases). Independent predictors for MAEs included age (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.00-1.02; P = .02), chronic kidney disease (OR, 1.88; 95% CI, 1.54-2.29; P ≤ .001), ASA class ≥3 (OR, 1.70; 95% CI, 1.21-2.38; P = .002), previous aortic repair (OR, 0.74; 95% CI, 0.60-0.91; P = .004), symptomatic/ruptured (OR, 1.76; 95% CI, 1.36-2.28; P < .001), extent I to III TAAA (OR, 2.28; 95% CI, 1.75-2.97; P < .001), and lower annual volume (<11 cases/year: OR, 1.83; 95% CI, 1.40-2.38; P < .001). Symptomatic/ruptured TAAA was an independent predictor for FTR (OR, 2.99; 95% CI, 1.62-5.52; P < .001).
Conclusions: FB-EVAR was performed with low in-hospital mortality. Lower volume centers had higher rates of MAEs, but center volume was not related to FTR. Symptomatic/ruptured TAAAs were independently predictive of FTR.
Keywords: Failure to rescue; Fenestrated-branched endovascular aortic repair; In-hospital mortality; Major adverse events; Thoracoabdominal aortic aneurysm.
Copyright © 2025 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures B.C.M. reports consulting and research funding from Cook Medical and W. L. Gore; and scientific advisory board of Cook Medical and Medtronic. D.B.S. reports consulting, research grants, and/or advisory boards for Cook Medical, Medtronic, Philips, WL Gore, and ViTAA. S.H. reports consulting and intellectual property expertise for Cook Medical, GE Healthcare, and Bentley. J.S. reports consulting, research grants and/or advisory boards for Cook Medical, WL Gore, and GE Healthcare. A.B. reports consulting, research grants and/or advisory boards for Artivion, Cook Medical, Medtronic, Philips, WL Gore, and Terumo. A.S. reports consulting, research grants and/or advisory boards for Cook Medical, Philips Imaging, and Artivion. M.F. reports consulting, research grants, and/or advisory boards for Cook Medical, WL Gore, ViTAA, Centerline, and Getinge. C.T. reports consulting, research grants, and/or advisory boards for Cook Medical and WL Gore. A.K. reports consulting, research grants and/or advisory board for Cook Medical, Medtronic, WL Gore, Terumo, and Getinge. T.K. reports consulting, royalties, research grants, and/or advisory boards for Cook Medical, Philips, Terumo Aortic, and Getinge. B.M. reports consulting, research grants, and/or advisory boards for Cook Medical, WL Gore, Philips, and Bentley. M.G. reports proctoring fees for Cook Medical. N.V.D. reports consulting, research grants, and/or advisory boards for Cook Medical, Medtronic, WL Gore, and Siemens Heathneers. K.M. reports consulting and institutional grant for Cook Medical. L.M.P. reports speaking and proctoring fees for Cook Medical; and speaking fees for WL Gore and Terumo aortic. K.K.Y. reports consulting fees and research grants from WL Gore, Medtronic, Artivion; consulting fees from Terumo Aortic; and research grants from the Dutch Heart Foundation and Horizon Europe, European Commission. N.T. reports consulting and research grants from Cook Medical, Medtronic, Bentley, Siemens, iVascular, and Terumo Aortic. T.R. reports consulting grants for Cook Medical, WL Gore, Philips, and Artivion. L.B. reports consulting, research grants and/or advisory boards for Cook Medical. M.K. reports consulting, research grants, and/or advisory boards for Medtronic and WL Gore. G.W.S. reports consulting, research grants, and/or advisory boards for Cook Medical and Philips. E.G. reports proctoring fees for Cook Medical. A.W. reports institutional educational grant from Cook Medical. R.G.M. reports speaking fees for Cook Medical. K.K. reports research grant from Medtronic. G.S.O. reports consulting, research grants and/or advisory boards for Cook Medical, WL Gore, GE Healthcare, and Centerline.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
